Solvay (SOLB) AGM 2025 Presentation summary
Event summary combining transcript, slides, and related documents.
AGM 2025 Presentation summary
2 Jul, 2025Safety and operational excellence
Safety culture strengthened with a dedicated team and external consultants; three fatalities in 2023 led to an action plan for transformation and leadership engagement.
Operational excellence driven by standardization, digitalization, and cost savings, targeting €350 million in annual gross savings by 2028.
Strategic direction and business model
Focus on essential chemicals, positioned between commodity and specialty segments, with market and cost leadership as core drivers.
Portfolio includes leading businesses in soda ash, peroxides, silica, and rare earths, serving diverse end-markets such as automotive, construction, and healthcare.
Over 80% of sales are regional, with a global footprint across North America, Latin America, Europe, and Asia.
Sustainability and energy transition
"For Generations" roadmap sets refreshed sustainability ambitions, including a 30% biodiversity land commitment and coal phase-out at key sites.
CO2 emissions reduced by half over 20 years; targets include -30% Scope 1 & 2 GHG by 2030 and carbon neutrality by 2050.
Process innovation (e.Solvay) aims to cut soda ash CO2 emissions by 50% and reduce resource consumption.
Latest events from Solvay
- Strong 2025 results with robust cash flow, cost savings, and accelerated sustainability initiatives.SOLB
Roadshow presentation6 Mar 2026 - 2025 delivered strong cash flow and margins; 2026 outlook cautious with EBITDA €770–850m.SOLB
Q4 202524 Feb 2026 - Sequential EBITDA and margin gains offset year-over-year declines, with guidance upgraded.SOLB
Q2 20242 Feb 2026 - 2024 saw resilient EBITDA, strong cost savings, and reaffirmed growth and sustainability targets.SOLB
Q4 202422 Jan 2026 - Q3 2024 delivered resilient sales and EBITDA, with guidance confirmed at the high end.SOLB
Q3 202422 Jan 2026 - Q3 sales and EBITDA fell 7%, but margins, cash flow, and guidance remained robust.SOLB
Q3 202522 Jan 2026 - Q1 2025 sales and EBITDA fell 6%, but margins held and 2025 guidance is reaffirmed.SOLB
Q1 202522 Jan 2026 - Q2 2025 sales and EBITDA fell on soft demand, but margins and cash flow stayed resilient.SOLB
Q2 202522 Jan 2026